RecruitingPhase 4NCT06492512

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy


Sponsor

Southern Illinois University

Enrollment

120 participants

Start Date

May 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria1

  • Pregnant patients will be enrolled at less than 30 weeks gestational age (GA) with laboratory confirmed IDA (as defined by hemoglobin under 10.5 g/dL, as well as ferritin under 15 mcg/L)

Exclusion Criteria1

  • Patients <18 years old, patients who have severe IDA that requires blood transfusion or IV iron infusion, patients who have other known hemoglobinopathy (such as thalassemia or sickle cell anemia) or anemia of different mechanism (such as vitamin B12 or folate deficiency), patients with ulcerative colitis, Crohn's disease, gastric ulcers, patients who have previously undergone gastric bypass surgery, patients who experience admission for antepartum bleed, have been diagnosed with abnormal placentation (i.e., placenta previa, placenta accreta, placenta increta or percreta)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGdaily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill daily

DRUGalternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill every other day


Locations(1)

Southern Illinois University School of Medicine

Springfield, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06492512


Related Trials